External Company Press Release
Implant Solution That Prevents Leg Amputations
Osteopore International has successfully developed a bioresorbable 3D printed cage that prevents leg amputations in patients with severe lower leg fractures. The 3D printed cage helps a patient regenerate new bone cells and has been successfully designed and implanted in its first patient.
IDTechEx Research Subscribers
Skin Patches & e-Textiles at CES 2021
This premium article covers the major launches and themes in the niche wearable technology product areas of skin patches and e-textiles. Despite the "consumer" focus of the event, much of the discussion and product launches of note focused around health and wellness applications, including products on both the consumer and medical side of the regulatory barriers. This article reviews some of the prominent announcements and companies present at this year's virtual event.
IDTechEx Research Subscribers
Digital Health at CES 2021
CES is the world's largest and most influential technology event. Held annually in the first week of January in Las Vegas, USA, the ongoing COVID-19 pandemic forced CES 2021 onto an online platform. This IDTechEx premium article addresses some of the key themes and trends discussed during the digital health conference sessions at CES 2021.
IDTechEx Research Subscribers
Nanotechnology: Highlights from Academic Research in 2020
Examining published academic research gives great insight into the technologies of the future. In this premium article, IDTechEx consider highlights from the world of nanotechnology (i.e., involving particles and phenomena that occur between 1 and 500 nm) that were published over the last 12 months.
IDTechEx Research Subscribers
AI in Drug Discovery - Predicting and Optimising Compound Properties
This IDTechEx premium article provides an overview and analysis of the technologies, players and company landscape for AI predicting and optimising compound properties.
External Company Press Release
Merck Today Announced the Acquisition of AmpTec
Merck acquires AmpTec to expand mRNA capabilities for vaccines, treatments and diagnostics. Adds to Merck's lipid manufacturing expertise, providing an integrated offering across mRNA value chain